MeSH tree: C15.378.100
Why is it rare for dangerous blood clots to form in our blood? What happens if this safety mechanism fails? An international team of researchers involving the University of Greifswald has taken a major step toward finding ...
Jun 30, 2026
0
4
A simple shot given shortly after birth can protect babies from a rare but potentially life-threatening condition known as vitamin K deficiency bleeding (VKDB). When newborns don't have enough vitamin K, their blood can't ...
When a baby is born, hospital staff move quickly through a standard checklist of newborn care: taking measurements, administering antibiotic eye ointment to prevent eye infections, and giving a small injection of vitamin ...
May 15, 2026
0
14
For people living in regional and remote communities, where access to a GP or pathology services can involve long travel distances and large out-of-pocket expenses, point-of-care testing (POCT) offers a convenient way to ...
May 13, 2026
0
3
Severe bleeding after trauma can rapidly become life-threatening. In a new doctoral thesis from Karolinska Institutet, Marcus Wannberg examines how the body's coagulation system begins to fail early after injury, which injuries ...
May 6, 2026
0
4
Increasing numbers of parents are refusing vitamin K shots for their newborns, putting infants at greater risk of avoidable brain injuries, according to a preliminary systematic review released February 26, 2026, that will ...
Feb 26, 2026
0
13
Results from a new clinical trial led by Wake Forest University School of Medicine and Atrium Health Levine Cancer show that a new therapy could provide significantly better outcomes for patients with high-risk essential ...
Feb 10, 2026
0
10
A study led by scientists at the Centro Nacional de Investigaciones Carlos III (CNIC) demonstrates that stroke severity depends on the time of day the event occurs. The research shows that neutrophils—the most abundant immune ...
Jan 21, 2026
0
8
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Dec 16, 2025
0
10
For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five years, according to a ...
Dec 10, 2025
0
9
